These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 31982228)

  • 1. Corrigendum to "MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathways" [Cancer Letters 337 (2013) 226-236].
    Bao L; Yan Y; Xu C; Ji W; Shen S; Xu G; Zeng Y; Sun B; Qian H; Chen L; Wu M; Chen J; Su C
    Cancer Lett; 2020 Jun; 480():49-50. PubMed ID: 31982228
    [No Abstract]   [Full Text] [Related]  

  • 2. Corrigendum to "MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathways" [Canc. Lett. 337 (2013) 226-236].
    Bao L; Yan Y; Xu C; Ji W; Shen S; Xu G; Zeng Y; Sun B; Qian H; Chen L; Wu M; Chen J; Su C
    Cancer Lett; 2020 Mar; 473():198-199. PubMed ID: 31926781
    [No Abstract]   [Full Text] [Related]  

  • 3. MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathways.
    Bao L; Yan Y; Xu C; Ji W; Shen S; Xu G; Zeng Y; Sun B; Qian H; Chen L; Wu M; Su C; Chen J
    Cancer Lett; 2013 Sep; 337(2):226-36. PubMed ID: 23684551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. microRNA-19a-3p promotes tumor metastasis and chemoresistance through the PTEN/Akt pathway in hepatocellular carcinoma.
    Jiang XM; Yu XN; Liu TT; Zhu HR; Shi X; Bilegsaikhan E; Guo HY; Song GQ; Weng SQ; Huang XX; Dong L; Janssen HLA; Shen XZ; Zhu JM
    Biomed Pharmacother; 2018 Sep; 105():1147-1154. PubMed ID: 30021351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.
    McCubrey JA; Steelman LS; Abrams SL; Lee JT; Chang F; Bertrand FE; Navolanic PM; Terrian DM; Franklin RA; D'Assoro AB; Salisbury JL; Mazzarino MC; Stivala F; Libra M
    Adv Enzyme Regul; 2006; 46():249-79. PubMed ID: 16854453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retraction: MicroRNA-367 promotes progression of hepatocellular carcinoma through PTEN/PI3K/AKT signaling pathway.
    Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32167152
    [No Abstract]   [Full Text] [Related]  

  • 7. Hydrogen sulfide acts as a double-edged sword in human hepatocellular carcinoma cells through EGFR/ERK/MMP-2 and PTEN/AKT signaling pathways.
    Wu D; Li M; Tian W; Wang S; Cui L; Li H; Wang H; Ji A; Li Y
    Sci Rep; 2017 Jul; 7(1):5134. PubMed ID: 28698660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTEN: A potential prognostic marker in virus-induced hepatocellular carcinoma.
    Khalid A; Hussain T; Manzoor S; Saalim M; Khaliq S
    Tumour Biol; 2017 Jun; 39(6):1010428317705754. PubMed ID: 28621226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RAS/RAF/MEK/ERK, PI3K/PTEN/AKT/mTORC1 and TP53 pathways and regulatory miRs as therapeutic targets in hepatocellular carcinoma.
    Akula SM; Abrams SL; Steelman LS; Emma MR; Augello G; Cusimano A; Azzolina A; Montalto G; Cervello M; McCubrey JA
    Expert Opin Ther Targets; 2019 Nov; 23(11):915-929. PubMed ID: 31657972
    [No Abstract]   [Full Text] [Related]  

  • 10. Synergistic anticancer activity of 20(S)-Ginsenoside Rg3 and Sorafenib in hepatocellular carcinoma by modulating PTEN/Akt signaling pathway.
    Lu M; Fei Z; Zhang G
    Biomed Pharmacother; 2018 Jan; 97():1282-1288. PubMed ID: 29156516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long Noncoding RNA lncARSR Promotes Doxorubicin Resistance in Hepatocellular Carcinoma via Modulating PTEN-PI3K/Akt Pathway.
    Li Y; Ye Y; Feng B; Qi Y
    J Cell Biochem; 2017 Dec; 118(12):4498-4507. PubMed ID: 28464252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver cancer cells are sensitive to Lanatoside C induced cell death independent of their PTEN status.
    Durmaz I; Guven EB; Ersahin T; Ozturk M; Calis I; Cetin-Atalay R
    Phytomedicine; 2016 Jan; 23(1):42-51. PubMed ID: 26902406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cross-talk between PI3K/Akt and MEK/ERK pathways regulates human hepatocellular carcinoma cell cycle progression under endoplasmic reticulum stress].
    Yan DM; Dai RY; Duan CY; Chen SK; Liu YP; Chen CN; Li H
    Zhonghua Gan Zang Bing Za Zhi; 2010 Dec; 18(12):909-14. PubMed ID: 21205476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HSulf-1 modulates HGF-mediated tumor cell invasion and signaling in head and neck squamous carcinoma.
    Lai JP; Chien J; Strome SE; Staub J; Montoya DP; Greene EL; Smith DI; Roberts LR; Shridhar V
    Oncogene; 2004 Feb; 23(7):1439-47. PubMed ID: 14973553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha1-ACT Functions as a Tumour Suppressor in Hepatocellular Carcinoma by Inhibiting the PI3K/AKT/mTOR Signalling Pathway via Activation of PTEN.
    Zhu H; Liu Q; Tang J; Xie Y; Xu X; Huang R; Zhang Y; Jin K; Sun B
    Cell Physiol Biochem; 2017; 41(6):2289-2306. PubMed ID: 28456796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rpn10 promotes tumor progression by regulating hypoxia-inducible factor 1 alpha through the PTEN/Akt signaling pathway in hepatocellular carcinoma.
    Jiang Z; Zhou Q; Ge C; Yang J; Li H; Chen T; Xie H; Cui Y; Shao M; Li J; Tian H
    Cancer Lett; 2019 Apr; 447():1-11. PubMed ID: 30673593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrine derivative WM130 inhibits hepatocellular carcinoma by suppressing EGFR/ERK/MMP-2 and PTEN/AKT signaling pathways.
    Qian L; Liu Y; Xu Y; Ji W; Wu Q; Liu Y; Gao Q; Su C
    Cancer Lett; 2015 Nov; 368(1):126-134. PubMed ID: 26259512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTEN Promotes Dopaminergic Neuronal Differentiation Through Regulation of ERK-Dependent Inhibition of S6K Signaling in Human Neural Stem Cells.
    Lee JE; Lim MS; Park JH; Park CH; Koh HC
    Stem Cells Transl Med; 2016 Oct; 5(10):1319-1329. PubMed ID: 27388240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human Sulfatase-1 Improves the Effectiveness of Cytosine Deaminase Suicide Gene Therapy with 5-Fluorocytosine Treatment on Hepatocellular Carcinoma Cell Line HepG2 In Vitro and In Vivo.
    Yang XP; Liu L; Wang P; Ma SL
    Chin Med J (Engl); 2015 May; 128(10):1384-90. PubMed ID: 25963362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-21 acts as an oncomir through multiple targets in human hepatocellular carcinoma.
    Liu C; Yu J; Yu S; Lavker RM; Cai L; Liu W; Yang K; He X; Chen S
    J Hepatol; 2010 Jul; 53(1):98-107. PubMed ID: 20447717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.